These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30276642)

  • 1. A New N Staging System for Colorectal Cancer in the Era of Extended Lymphadenectomy.
    Shinto E; Hida JI; Ike H; Kobayashi H; Hashiguchi Y; Hase K; Ueno H; Sugihara K
    Ann Surg Oncol; 2018 Dec; 25(13):3891-3897. PubMed ID: 30276642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prominent Information of jN3 Positive in Stage III Colorectal Cancer Removed by D3 Dissection: Retrospective Analysis of 6866 Patients From a Multi-institutional Database in Japan.
    Shinto E; Hida JI; Kobayashi H; Hashiguchi Y; Hase K; Ueno H; Watanabe T; Sugihara K
    Dis Colon Rectum; 2018 Apr; 61(4):447-453. PubMed ID: 29521826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topographic lymph node staging system shows prognostic superiority compared to the 8th edition of AJCC TNM in gastric cancer. A western monocentric experience.
    Lauricella S; Caricato M; Mascianà G; Carannante F; Carnazza M; Bonaccorso A; Angeletti S; Ciccozzi M; Coppola R; Capolupo GT
    Surg Oncol; 2020 Sep; 34():223-233. PubMed ID: 32869748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal colorectal cancer staging criteria in TNM classification.
    Ueno H; Mochizuki H; Akagi Y; Kusumi T; Yamada K; Ikegami M; Kawachi H; Kameoka S; Ohkura Y; Masaki T; Kushima R; Takahashi K; Ajioka Y; Hase K; Ochiai A; Wada R; Iwaya K; Shimazaki H; Nakamura T; Sugihara K
    J Clin Oncol; 2012 May; 30(13):1519-26. PubMed ID: 22430272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognosis of N2b and N2c lymph node disease in oral squamous cell carcinoma is determined by the number of metastatic lymph nodes rather than laterality: evidence to support a revision of the American Joint Committee on Cancer staging system.
    Ebrahimi A; Gil Z; Amit M; Yen TC; Liao CT; Chaturvedi P; Agarwal JP; Kowalski LP; Kohler HF; Kreppel M; Cernea CR; Brandao J; Bachar G; Bolzoni Villaret A; Fliss D; Fridman E; Robbins KT; Shah JP; Patel SG; Clark JR;
    Cancer; 2014 Jul; 120(13):1968-74. PubMed ID: 24691658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verification of the Japanese staging system for rectal cancer, focusing on differences with the TNM classification.
    Arabiki M; Shimada Y; Nakano M; Tanaka K; Oyanagi H; Nakano M; Ling Y; Okuda S; Takii Y; Wakai T
    Surg Today; 2020 Nov; 50(11):1443-1451. PubMed ID: 32440825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
    Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
    World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic accuracy of different lymph node staging system in predicting overall survival in stage IV colon cancer.
    Han L; Mo S; Xiang W; Li Q; Wang R; Xu Y; Dai W; Cai G
    Int J Colorectal Dis; 2020 Feb; 35(2):317-322. PubMed ID: 31858220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposed modifications of supraclavicular lymph node metastasis in the esophageal squamous cell carcinoma staging system for improved survival stratification.
    Zheng Y; Wang Z; Wang F; Huang Q; Liu S
    Oncotarget; 2017 Jun; 8(25):41563-41571. PubMed ID: 28147340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
    Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
    Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative to positive lymph node ratio is a superior predictor than traditional lymph node status in stage III colorectal cancer.
    Li Q; Liang L; Jia H; Li X; Xu Y; Zhu J; Cai S
    Oncotarget; 2016 Nov; 7(44):72290-72299. PubMed ID: 27474167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing nodal and staging classification in low rectal cancers with lateral node metastasis: multicentre retrospective cohort study.
    Shinto E; Ike H; Ito M; Takahashi K; Ohue M; Kanemitsu Y; Suto T; Kinugasa T; Watanabe J; Hida JI; Itabashi M; Ozawa H; Nozawa H; Kobayashi H; Hashiguchi Y; Hase K; Sugihara K
    BJS Open; 2022 Mar; 6(2):. PubMed ID: 35257141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
    Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
    Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Significance of International Union Against Cancer pN Staging and Lymph Node Ratio in Node-Positive Colorectal Cancer after Advanced Lymph Node Dissection.
    Märkl B; Olbrich G; Schenkirsch G; Kretsinger H; Kriening B; Anthuber M
    Dis Colon Rectum; 2016 May; 59(5):386-95. PubMed ID: 27050600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of lymph node status in patients with metastatic colorectal carcinoma treated with lymphadenectomy.
    Liu YL; Xu HT; Jiang SX; Yang YM; Cui BB
    J Surg Oncol; 2014 Mar; 109(3):234-8. PubMed ID: 24449194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic lymph node ratio as a better prognostic tool than the TNM system in colorectal cancer.
    Macedo F; Sequeira H; Ladeira K; Bonito N; Viana C; Martins S
    Future Oncol; 2021 Apr; 17(12):1519-1532. PubMed ID: 33626938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.